feed,title,long_url,short_url
Benzinga,"Gilead Q4 Earnings Highlights: Remdesivir Sales Fall 30%, Raises Dividend, FY22 EPS Below Estimates",https://benzinga.com/general/biotech/22/02/25359339/gilead-q4-earnings-highlights-remdesivir-sales-fall-30-raises-dividend-fy22-eps-below-estimates,https://bit.ly/3L1lAzP
